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Abstract
Introduction: In rare instances, demyelinating disorders manifest as tumefactive lesions that simulate brain tumors.
We report a patient with a space-occupying lesion in the parietal lobe, which presented a serious diagnostic
dilemma, between a rare tumefactive demyelinating disease, such as Balo concentric sclerosis and a glioma. This
case report highlights important diagnostic clues in the differential diagnosis of Balo concentric sclerosis.
Case presentation: A 20-year-old Caucasian woman with acute onset of left-sided weakness and numbness was
admitted to hospital with neurologic signs of left-sided hemiparesis and hypoesthesia. Brain magnetic resonance
imaging showed a mass lesion of abnormal signal intensity with concentric enhancing rings in the right parietal
lobe, without perifocal edema. The characteristic concentric pattern detected on the magnetic resonance images
was highly suggestive of Balo disease, and corticosteroids were administered. Evoked potentials, cerebrospinal fluid
analysis, and magnetic spectroscopy findings were not specific, and glioma was also included in the differential
diagnosis. A stereotactic biopsy was not diagnostic.
After one month the patient showed moderate clinical improvement, and during 12 months follow-up, no further
relapses occurred. In the follow-up magnetic resonance imaging, the concentric pattern had completely
disappeared, and only a low-signal, gliotic lesion remained.
Conclusion: We hope this case presentation will advance our understanding of clinical and radiologic appearance
of Balo concentric sclerosis, which is a rare demyelinating disease. Although this is a specific entity, it has a broader
clinical impact across medicine, because it must be differentiated from other space-occupying lesions in the central
nervous system.
Introduction
Tumefactive demyelinating brain lesions present a diag-
nostic challenge, because their clinical, radiologic, and
even histologic features may complicate the identifica-
tion of their true nature. This often leads to invasive
and costly procedures, which frequently yield non-diag-
nostic results. We report a patient with a right parietal
white matter lesion, who presented a serious diagnostic
dilemma, as the lesion was difficult to differentiate
between a rare demyelinating disease such as Balo con-
centric sclerosis (BCS) and a glioma. The characteristic
magnetic resonance findings of the case, its acute onset,
and its clinical improvement after corticosteroid therapy
finally set the diagnosis of BCS. The risks of the
stereotactic procedures that led to the misdiagnosis of
BCS are discussed.
Case presentation
A 20-year-old Caucasian woman, with no past medical
history, presented to the emergency room of a general
hospital, with numbness and weakness of her left-sided
limbs. Neurologic examination revealed no cranial nerve
deficit and 4/5 left-sided hemiparesis. No cerebellar
impairment was noted. She was unable to localize tactile
stimuli or to judge objects’ size and shape. She had no
pain, pressure, or temperature loss. Brain computed
tomography (CT) demonstrated a large (2.1 cm), well-
demarcated hypodense lesion in the right parietal lobe,
without perifocal edema. Magnetic resonance imaging
(MRI) without contrast showed a hypoisointense con-
centric mass on T1-a n dh y p e r i n t e n s eo nT 2-weighted
images (Figure 1a, b). After contrast, the lesion appeared
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separate, alternating enhancing rings (Figure 1c). These
MRI findings were highly suggestive of the concentric
pattern of demyelination (BCS).
Somatosensory evoked potentials (SSEPs), serum, and
cerebrospinal fluid analysis were normal. Human immu-
nodeficiency virus (HIV) and antinuclear antibody
(ANA) tests were negative. The chest radiograph (CXR)
was normal. Under the presumptive diagnosis of BCS,
the patient received high-dose intravenously adminis-
tered methylprednisolone (500 mg/day for ten days).
The subsequent proton MR spectroscopy (MRS)
revealed reduction in N-acetylaspartate and an increase
in choline, lipids, and lactate. The findings were not
specific and were consistent either with an acute demye-
linating lesion or with a low-grade glioma. Ten days
later, the patient showed moderate clinical improvement
and continued with oral steroid treatment.
A brain CT-guided stereotactic biopsy was scheduled
to establish the diagnosis, as MRS and laboratory find-
ings were not specific. Four specimens within and from
the periphery of the lesion were taken. Histologic exami-
nation failed to show the presence of a significant num-
ber of histiocytes, foamy macrophages, or myelin loss
that would otherwise be expected in Balo sclerosis. It
showed, however, mild to moderate nuclear atypia,
Figure 1 Brain MR images in a 20-year-old woman. (a) Axial T2-weighted image shows a hyperintense mass with concentric pattern in the
right centrum semiovale. (b) Axial T1-weighted image reveals hypoisointense concentric rings in the white matter of the right parietal lobe. (c)
Axial T1-weighted image after contrast shows concentric enhancing rings. (d) Axial T2-weighted image, 1 month after therapy, shows differences
with decrease of the signal intensity at the center of the lesion. (e, f) Coronal T1-weighted image after administration of gadolinium
demonstrates a low-signal, non-enhancing lesion.
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of the nuclei. The pathologist commented that the find-
ings were suggestive of a grade II astrocytoma.
In the face of this diagnostic dilemma, a conservative
approach was adopted. Oral steroid treatment was
continued, and the patient was scheduled for a new 1H-
MRS and MRI scan one month later. The spectroscopic
findings were identical to the previous ones. However,
the new conventional MRI images showed significant
differences, in that the signal intensity was lower in the
center of the lesion in T2 images (Figure 1d), whereas
the enhancing rings appeared to fade away centrifugally
(Figure 1e, f). The dimensions of the lesion were
unchanged. These findings were considered sufficient
enough to establish the diagnosis of BCS.
No relapse in the symptoms occurred during the next
12 months of follow-up. A serial MRI showed a low-
signal, non-enhancing lesion.
Discussion
Diagnosis of tumefactive brain lesions is challenging to
both clinicians and radiologists. Clinical differential
diagnosis includes demyelinating diseases, neoplasms,
and infections such as abscesses. Such lesions with
mass-like characteristics may be the presenting feature
of multiple sclerosis (MS), acute disseminated encepha-
lomyelitis, or other rare demyelinating diseases, such as
BCS and Marburg type. BCS is a rare demyelinating dis-
ease considered to be an acute variant of MS, appearing
in young adults and typically following a fulminant
course [1]. It shows a monophasic, rapidly progressive
course, sometimes fatal. Histologically, it is characterized
by a large lesion consisting of rings of demyelination
alternating with rings of intact myelin. MRI is the
method of choice for imaging demyelination lesions,
tumefactive or not. Although the usual appearance of
MS is that of multiple, small, demyelinating plaques, in
some cases, it can simulate a mass lesion, which it
would be hard to distinguish from a brain tumor [2].
MRI characteristics, such as open-ring enhancement,
peripheral restriction on diffusion-weighted imaging, or
venular enhancement, may be rewarding in differentiat-
ing tumefactive MS lesions from neoplastic ones [2].
BCS is also considered within the spectrum of MS. It
shares an apparent basic pathologic similarity to MS,
with the exception of a lamellar pattern. The striking
concentric pattern of demyelination distinguishes this
disorder from other demyelinating diseases. BCS has
characteristic MRI features such as the hypoisointense
concentric rings on T1-weighted, the whirlpool hyperin-
tense concentric rings on T2-weighted, and the separate
rings of enhancement in a concentric pattern [3]. This
type of concentric pattern has not been described in
association with any other demyelinating/inflammatory
diseases except BCS, and therefore, acute disseminated
encephalomyelitis and Marburg MS were excluded in
our case.
Advanced neuroimaging can provide important in vivo
markers of disease progression. MRS in BCS may show
reduction of N-acetylaspartate and increase in choline
and lipids, reflecting axonal destruction and an elevation
of lactate resonance due to local ischemia from the
ongoing inflammatory process [4]. These resonance
spectra [2,4] are not specific for BCS, and they may
resemble those of brain tumors and acute MS plaques
[2,4,5]. The chronic demyelinating plaque, however,
shows a completely different pattern [4].
A stereotactic biopsy and histologic examination of
the lesion is the final diagnostic approach in equivocal
cases [6]. It is safe and reliable, especially if specimens
from multiple sites within the lesion are targeted. It has
a diagnostic accuracy of 82% to 99% [7]. Acute demyeli-
nating plaque is hypercellular, and on frozen sections,
this hypercellularity may be mistaken to be indicative of
glioma. The diffuse infiltration of inflammatory cells,
mainly reactive astrocytes and lipid-laden macrophages,
and perivascular cuffing by T-lymphocytes favors the
diagnosis of demyelinating plaque. The presence of
alternating rings of myelin preservation or remyelination
and myelin loss, consistent with demyelination, corre-
sponds to the concentric type of demyelination, or BCS.
Although the presence of reactive astrocytes can raise
the diagnosis of an astrocytoma, in the non-neoplastic
demyelinating plaque, these astrocytes are not significant
in number to establish such a diagnosis safely, nor are
there areas of vascular proliferation, indicative of a
neoplastic process. Staining for myelin and axons and
applying special immunohistochemical stains for macro-
phage markers should help overcome this diagnostic
pitfall [8].
Occasionally, the biopsy is non-diagnostic or dispensa-
ble [5]. In our case, the risk lay in the fact that in BCS,
areas of demyelination alternate with areas of active
gliosis in a dynamic and concentric fashion. Even with
the use of stereotactic procedures, tissue specimens may
be yielded from area of reactive gliosis not just outside,
but also from within the lesion itself, thus giving ambig-
uous or false results. Targeting multiple areas within the
lesion may help overcome this problem.
In our case, histopathologic findings from the biopsy
were misleading.
However, the characteristic concentric rings of demye-
lination alternating with myelination on MRI, the
patient’s considerable clinical improvement after steroid
therapy, and the signal differences in follow-up MRI
scans established the diagnosis of BCS.
In serial MRI scans, the concentric ring enhancement
of BCS is expected to fade away centrifugally, until it
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a chronic demyelinating plaque [9], as in our case.
Regarding MRS, it seems that it is the serial changes of
the metabolites’ resonance intensities rather than the
individual values that provide more information about
the nature of the lesion [9].
Conclusion
Demyelinating diseases can mimic brain neoplasms
clinically, radiologically, and histopathologically. BCS is
a rare demyelinating disease, which can manifest as a
mass lesion. The typical concentric pattern on MR
images, along with clinical features, can lead to accurate
diagnosis and treatment. For suspected cases, it is advi-
sable to use steroid therapy or undergo serial MRI
examinations. However, in borderline cases, pathologic
evidence is beneficial to a final diagnosis.
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